Tag: Metastatic Merkel Cell Cancer Therapy

Home / Metastatic Merkel Cell Cancer Therapy

Categories

Retifanlimab-dlwr is approved by FDA for metastatic or recurrent locally advanced Merkel cell carcinoma

April 2023: Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent locally advanced Merkel cel...
metastatic-merkel-cell-cancer-therapy

Scan the code